AstraZeneca asthma drug fails, after similar setback at Roche

loading...


AstraZeneca asthma drug fails, after similar setback at Roche
(Reuters) – An experimental biotech drug for severe asthma from AstraZeneca failed to meet its goal of significantly reducing attacks in a late-stage study, dealing a blow to an approach that had already run into problems at Roche .


Source: Health And Fitness

Reply

Pin It on Pinterest

Shares
Share This
loading...